Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAPI-PRO: [18F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Pancreatic Ductal Adenocarcinoma
NCT07217717Phase 3Recruiting
- Sponsor
- SOFIE
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of [18F]-FAPI-74 in pancreatic ductal adenocarcinoma (PDAC), sponsored by SOFIE. Started Dec 2025; status: recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT07217717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07217717.